- 专利标题： Biological targeting compositions and methods of using the same
-
申请号： US12228893申请日： 2008-08-13
-
公开(公告)号： US20100042072A1公开(公告)日： 2010-02-18
- 发明人: Roderick A. Hyde , Muriel Y. Ishikawa , Edward K.Y. Jung , William Gates , Alois A. Langer , Eric C. Leuthardt , Royce A. Levien , Clarence T. Tegreene , Thomas A. Weaver , Charles Whitmer , Lowell L. Wood, JR. , Victoria Y.H. Wood
- 申请人： Roderick A. Hyde , Muriel Y. Ishikawa , Edward K.Y. Jung , William Gates , Alois A. Langer , Eric C. Leuthardt , Royce A. Levien , Clarence T. Tegreene , Thomas A. Weaver , Charles Whitmer , Lowell L. Wood, JR. , Victoria Y.H. Wood
- 专利权人： Searete LLC, a limited liability corporation of the State of Delaware
- 当前专利权人： Searete LLC, a limited liability corporation of the State of Delaware
- 主分类号： A61M31/00
- IPC分类号： A61M31/00 ; A61K35/18 ; A61B18/18
摘要：
Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.
信息查询
